Prednisone是皮质类固醇试剂,有免疫抑制作用。
Prednisone (Adasone) is a synthetic corticosteroid agent that is particularly effective as an immunosuppressant compound.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Lanza L, et al. Clin Exp Immunol, 1996, 103(3), 482-490.
[2] Wild GE, Waschke KA, Bitton A, Thomson AB. Aliment Pharmacol Ther. 18:309-17 (2003).
分子式 C21H26O5 |
分子量 358.43 |
CAS号 53-03-2 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 70 mg/mL |
Water <1 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02534402 | Chronic Obstructive Pulmonary Disease | Drug: Prednisone | University of British Columbia | Phase 4 | 2015-08-01 | 2016-10-31 |
NCT02689960 | Adrenal Insufficiency | Drug: 100mg prednisone suppository | Wuerzburg University Hospital | Phase 2 | 2016-04-01 | 2016-02-24 |
NCT01933724 | Granulomatosis With Polyangiitis|Wegener Granulomatosis|Vasculitis | Drug: 5 mg prednisone|Drug: 0 mg prednisone | University of South Florida|National Institutes of Health (NIH)|National Heart, Lung, and Blood Institute (NHLBI)|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Office of Rare Diseases (ORD)|National Center for Advancing Translational Science (NCATS)|Rare Diseases Clinical Research Network | 2014-02-01 | 2016-10-24 | |
NCT00294658 | Myasthenia Gravis | Procedure: thymectomy plus prednisone|Drug: prednisone alone | University of Alabama at Birmingham|National Institute of Neurological Disorders and Stroke (NINDS) | Phase 3 | 2006-06-01 | 2017-01-19 |
NCT01821040 | Polymyalgia Rheumatica | Drug: Lodotra庐|Drug: Prednisone IR (immediate release) | Mundipharma Research Limited | Phase 3 | 2013-03-01 | 2015-04-09 |
NCT02479490 | Metastatic Renal Cancer | Drug: Prednisone + Everolimus | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | Phase 2 | 2015-09-01 | 2016-09-28 |
NCT00580229 | Rheumatoid Arthritis | Drug: prednisone | University of South Florida | Phase 2|Phase 3 | 2007-12-01 | 2016-08-10 |
NCT01940094 | Granulomatosis With Polyangiitis | Drug: Prednisone 5 mg/day|Drug: Prednisone 0 mg/day | University of Pennsylvania|National Heart, Lung, and Blood Institute (NHLBI)|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Office of Rare Diseases (ORD)|National Center for Advancing Translational Science (NCATS)|Rare Diseases Clinical Research Network | Phase 3 | 2014-02-01 | 2017-02-21 |
NCT02702778 | Polymyalgia Rheumatica | Drug: Delayed-Release (DR) Prednisone|Drug: Immediate Release (IR) Prednisone | Dinora, Inc.|Analgesic Solutions|PharPoint Research, Inc. | Phase 4 | 2016-02-01 | 2016-03-03 |
NCT01452100 | Cholesterol Embolism Systemic | Drug: prednisone|Other: placebo | University Hospital, Toulouse|Ministry of Health, France | Phase 2 | 2011-06-01 | 2016-05-06 |
NCT01758120 | IgA Nephropathy | Drug: prednisone plus cyclophosphamide|Drug: Prednisone alone | Guangdong General Hospital | Phase 4 | 2012-12-01 | 2017-01-17 |
NCT01559727 | Heart Failure | Drug: prednisone|Drug: prednisone|Drug: prednisone | Hebei Medical University | Phase 3 | 2012-03-01 | 2013-08-27 |
NCT01809444 | Thyroid Associated Opthalmopathies | Drug: Prednisone+placebo of Doxycycline|Drug: Doxycycline+placebo of Prednisone | Sun Yat-sen University | Phase 2|Phase 3 | 2012-11-01 | 2013-12-07 |
NCT01002703 | Multiple Myeloma | Drug: Lenalidomide, Bendamustine, Prednisone | University of Leipzig|Celgene Corporation|Mundipharma Pte Ltd.|Amgen | Phase 1|Phase 2 | 2009-09-01 | 2011-08-11 |
NCT00686335 | Asthma | Drug: Lodotra|Drug: Cortancyl | Horizon Pharma Ireland, Ltd., Dublin Ireland | Phase 2 | 2008-06-01 | 2012-11-27 |
NCT01671423 | Cellulitis | Drug: Prednisone|Drug: Placebo | Albert Einstein Healthcare Network | 2012-08-01 | 2015-01-30 | |
NCT01133275 | Myelodysplastic Syndrome|MDS | Drug: Prednisone|Drug: Lenalidomide | H. Lee Moffitt Cancer Center and Research Institute|Celgene Corporation | Phase 2 | 2010-04-01 | 2016-10-25 |
NCT00110669 | Duchenne Muscular Dystrophy | Drug: Prednisone | Cooperative International Neuromuscular Research Group | Phase 3 | 2004-01-01 | 2011-10-26 |
NCT02282683 | Heart Failure|Hyperuricemia | Drug: prednisone | Hebei Medical University | Phase 2|Phase 3 | 2013-12-01 | 2017-01-11 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们